Medical Polymers market, Size and Share by 2035

Key Market Insights

• Currently, over 145 companies claim to manufacture various natural, semi-synthetic and synthetic pharmaceutical polymers; around 15% players develop more than three pharmaceutical polymer compositions
• 75% of the players claim to have the necessary expertise to produce thermoplastics; firms are primarily offering polymers for use in excipients, drug delivery and packaging
• The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions
• In pursuit of obtaining a competitive edge, industry stakeholders are actively upgrading their existing capabilities and adding new competencies to enhance their respective product portfolios
• The number of partnerships inked in this domain demonstrates the growing interest of industry stakeholders; ~30% of the deals were inked for product development
• DELT analysis focuses on monitoring the internal and external forces that may affect the strategic business of a company; further, it provides a consolidated view on the likely threats and opportunities within this domain
• The pharmaceutical polymers / medical polymers market is likely to grow at a steady pace, till 2035; the projected opportunity is anticipated to be well distributed across types of polymers, area of applications and key regions

Table of Contents

1. PREFACE

1.1.      Introduction

1.2.      Key Market Insights

1.3.      Scope of the Report

1.4.      Research Methodology

1.5.      Frequently Asked Questions

1.6.      Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1.      Chapter Overview

3.2.      Overview of Polymers

3.3.      Concluding Remarks                      

4. MARKET LANDSCAPE

4.1.      Chapter Overview

4.2.      Pharmaceutical Polymer / Medical Polymers Manufacturers: Overall Market Landscape

5. COMPANY COMPETITIVENESS ANALYSIS

5.1.      Chapter Overview

5.2.      Assumptions and Key Parameters

5.3.      Methodology

5.4.    Pharmaceutical Polymer / Medical Polymer Manufacturers: Company Competitiveness Analysis

6. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN NORTH AMERICA

6.1.      Chapter Overview

6.2.      Americhem

6.2.1.   Company Overview

6.2.2.   Pharmaceutical Polymers / Medical Polymers Focused Portfolio

6.2.3.   Recent Developments and Future Outlook

6.3.      Celanese

6.4.      Eastman

6.5.      Lubrizol Life Science

6.6.      LyondellBasell

7. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN EUROPE

7.1.      Chapter Overview

7.2.      Borealis

7.2.1.   Company Overview

7.2.2.   Pharmaceutical Polymers / Medical Polymers Focused Portfolio

7.2.3.   Recent Developments and Future Outlook

7.3.      Henkel

7.4.      KRAIBURG TPE

7.5.      SEQENS

7.6.      Solvay

8. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN ASIA-PACIFIC AND REST OF THE WORLD

8.1.      Chapter Overview

8.2.      Corel Pharma Chem

8.2.1.   Company Overview

8.2.2.   Pharmaceutical Polymers / Medical Polymers Focused Portfolio

8.2.3.   Recent Developments and Future Outlook

8.3.      Kuraray

8.4.      Phon Tech

8.5.      Sumitomo Chemical

8.6.      Zylog ElastoComp

9. PARTNERSHIPS AND COLLABORATIONS

9.1.      Chapter Overview

9.2.      Partnership Models

9.3.      Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations

10. PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS: DELT ANALYSIS

10.1.    Chapter Overview 

10.2.    Key Parameters

10.3.    Methodology

10.4.    DELT Analysis: Pharmaceutical Polymer / Medical Polymer Manufacturers

10.5.    Concluding Remarks

11. CASE STUDY: RECENT TRENDS RELATED TO PHARMACEUTICAL / MEDICAL POLYMERS

11.1     Chapter Overview

11.2     Recent Trends Related to Pharmaceutical / Medical Polymers

11.3.    Concluding Remarks

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

12.1.    Chapter Overview

12.2.    Key Assumptions and Forecast Methodology

12.3.    Pharmaceutical Polymers / Medical Polymers Market, 2023-2035

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

14.1.    Chapter Overview

14.2.    Cassion Biotech

14.3.    Celares

14.4.    Daikyo Seiko

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/medical-polymers-market.html

Learn from experts:  do you know about these emerging industry trends?

Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain

CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com